Global Acne Drugs Market 2016-2020 - Key Vendors are Allergan, Galderma, Stiefel & Valeant

December 3, 2015

DUBLIN,

Research and Markets (http://www.researchandmarkets.com/research/2hpc7x/global_acne_drugs) has announced the addition of the "Global Acne Drugs Market 2016-2020" report to their offering.

Rising awareness levels of acne and related treatment products are positively influencing the sales of acne products. Many people are availing different treatment options, increasing the demand for acne drugs. Companies are developing innovative products to meet this rising demand. New products such as Visonac by Photocure are likely to meet consumer needs.

According to the report, many acne drugs are available in the market. However, these drugs provide symptomatic treatment and do not cure the condition. Symptomatic treatment involves the reduction of acne lesions by almost 50% and not the suppression of acne recurrence. Most people with acne use isotretinoin to relieve their condition. However, this drug has teratogenic effects and cannot be prescribed for pregnant women.

Further, the report states that though the available drugs are effective in alleviating acne, they have certain harmful side effects. Dryness, burning, itching, flaking, irritation, and slight puffiness of the skin are some of the side effects of topical acne drugs. Oral drugs can also cause side effects. Solodyn (minocycline), an oral acne drug, has many side effects, and its administration requires medical supervision.

Key questions answered in the report include:

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Acne: An overview

PART 06: Pipeline analysis

PART 07: Market landscape

PART 08: Reimbursement scenario for acne drugs

PART 09: Market segmentation by drug class

PART 10: Market segmentation by route of administration

PART 11: Market segmentation by type

PART 12: Global acne drugs market: OTC drugs

PART 13: Geographical segmentation

PART 14: Market drivers

PART 15: Impact of drivers

PART 16: Market challenges

PART 17: Impact of drivers and challenges

PART 18: Market trends

PART 19: Vendor landscape

Key Vendors:

Other Prominent Vendors:

For more information visit http://www.researchandmarkets.com/research/2hpc7x/global_acne_drugs

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE:

Research and Markets